199 related articles for article (PubMed ID: 37018234)
21. Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
.
Ní Chonghaile M; Wolownik K
Clin J Oncol Nurs; 2018 Feb; 22(1):E7-E17. PubMed ID: 29350698
[TBL] [Abstract][Full Text] [Related]
22. Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.
Chen S; Osborn JD; Chen X; Boyer MW; McDonald GB; Hildebrandt GC
Int J Hematol; 2015 Dec; 102(6):729-31. PubMed ID: 26497867
[TBL] [Abstract][Full Text] [Related]
23. Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Nishida M; Sugita J; Takahashi S; Iwai T; Sato M; Kudo Y; Omotehara S; Horie T; Sakano R; Shibuya H; Yokota I; Iguchi A; Teshima T
Int J Hematol; 2021 Jul; 114(1):94-101. PubMed ID: 33763826
[TBL] [Abstract][Full Text] [Related]
24. Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
Esteves I; Santos FPS; Ribeiro AAF; Seber A; Sugawara EK; Sobrinho JJDN; Barros JC; Oliveira JSR; Fernandes JF; Hamerschlak N; Andersson BS; de Lima M; Kerbauy FR
Hematol Oncol; 2020 Dec; 38(5):773-781. PubMed ID: 32779746
[TBL] [Abstract][Full Text] [Related]
25. Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation.
Lee S; Lee E; Park SS; Park MS; Jung J; Min GJ; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW; Hwang HJ; Yoon JH
Bone Marrow Transplant; 2022 Apr; 57(4):538-546. PubMed ID: 35075247
[TBL] [Abstract][Full Text] [Related]
26. Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
Nishida M; Kahata K; Hayase E; Shigematsu A; Sato M; Kudo Y; Omotehara S; Iwai T; Sugita J; Shibuya H; Shimizu C; Teshima T
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1896-1900. PubMed ID: 29803752
[TBL] [Abstract][Full Text] [Related]
27. Spectral Doppler Ultrasound Can Help Diagnose Children With Hepatic Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation.
Thumar VD; Vallurupalli VM; Robinson AL; Staggs VS; Shah V; Dalal J; Chan SS
Ultrasound Q; 2020 Mar; 36(1):6-14. PubMed ID: 30921102
[TBL] [Abstract][Full Text] [Related]
28. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
29. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
30. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
Özkan HA; Özkan SG
Transfus Apher Sci; 2022 Feb; 61(1):103372. PubMed ID: 35101376
[TBL] [Abstract][Full Text] [Related]
31. A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation.
Kim M; Rao S; Eickhoff JC; DeSantes KB; Capitini CM
J Pediatr Hematol Oncol; 2020 Mar; 42(2):145-148. PubMed ID: 30676436
[TBL] [Abstract][Full Text] [Related]
32. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q
Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Inagaki J; Noguchi M; Fukano R
Pediatr Blood Cancer; 2020 Aug; 67(8):e28412. PubMed ID: 32495502
[TBL] [Abstract][Full Text] [Related]
34. High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.
Hwang DY; Kim SJ; Cheong JW; Kim Y; Jang JE; Lee JY; Min YH; Yang WI; Kim JS
Leuk Lymphoma; 2016; 57(1):51-7. PubMed ID: 25899401
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.
Rezvani AR; McCune JS; Storer BE; Batchelder A; Kida A; Deeg HJ; McDonald GB
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1033-9. PubMed ID: 23583825
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients.
Kerl K; Diestelhorst C; Bartelink I; Boelens J; Trame MN; Boos J; Hempel G
Pediatr Blood Cancer; 2014 Feb; 61(2):306-11. PubMed ID: 24174393
[TBL] [Abstract][Full Text] [Related]
37. Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
Stutz L; Halter JP; Heim D; Passweg JR; Medinger M
Bone Marrow Transplant; 2022 Mar; 57(3):391-398. PubMed ID: 34980902
[TBL] [Abstract][Full Text] [Related]
38. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
[TBL] [Abstract][Full Text] [Related]
39. Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT.
Berger K; Schopohl D; Rieger C; Ostermann H
Support Care Cancer; 2015 Dec; 23(12):3447-54. PubMed ID: 25773673
[TBL] [Abstract][Full Text] [Related]
40. Grayscale and Spectral Doppler Ultrasound in the Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children.
Kaya N
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1105-e1110. PubMed ID: 34673713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
